Incannex Healthcare Inc
Research Incannex Healthcare Inc (IXHL) on Bullrun: market cap USD 43.31M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerIXHL
- ExchangeNASDAQ
- CountryAustralia
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- CurrencyUSD
- Market capUSD 43.31M
- Financial periodFY2025
- RevenueUSD 86.00K
- Revenue growth616.7%
- Net income-USD 46.89M
- Free cash flow-USD 12.52M
Valuation Snapshot
latest market cap is USD 43.31M.
About Incannex Healthcare Inc
Incannex Healthcare Inc., a clinical-stage biopharmaceutical company, engages in the research and development of psychedelic medicines and therapies for patients with chronic diseases in Australia. The company develops IHL-42X, an oral fixed dose combination of dronabinol and acetazolamide that is in Phase 2/3 clinical trial for the treatment of obstructive sleep apnea; and PSX-001, an oral synthetic psilocybin treatment in Phase 2b clinical development for patients with generalized anxiety disorder.
Frequently asked questions
What is Incannex Healthcare Inc's market cap?
Incannex Healthcare Inc's market capitalization is USD 43.31M.
What does Incannex Healthcare Inc do?
Incannex Healthcare Inc., a clinical-stage biopharmaceutical company, engages in the research and development of psychedelic medicines and therapies for patients with chronic diseases in Australia.